NorthWest Biotherapeutics Inc (NWBO)

[IkeEsq]

. . . which is why I state: "That brings the total shares to 1.5-1.75 billion, depending on how many they sell."

As in 1.5 Billion if they sell none, something that seems unlikely as it has been reported that at least one person on this board has or intended to purchase some, and as much as 1.75 if they sell them all.

NWBO is the ones who decided on 10 MM shares convertible to 250 MM common shares. We should assume that they did so for a reason and that any increase in authorization of common shares will cover all of those shares should they decide to sell them now or in the future.

If they authorize additional shares, 1.5 Billion covers current outstanding shares, 1.75 covers outstanding shares plus ALL C shares if they sell them, and 2.0 Billion covers all outstanding, all C, and another 250 MM for future cash raises, partnerships, and management/board awards.

I have no idea how many C shares they will sell and made no guess. Why you assume that it will be all is beyond me. It is,however, unrealistic to think that they are going to raise the allocation to less than 1.75 billion, and I am willing to go as low as 2.0 billion for the top end.